Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multifocal medulloblastoma in an adult: a case report and review of the literature. | J Cancer Res Clin Oncol | 2025 | 40369375 | PubTator, text mining | PubMed |
| Clinicopathologic and Genomic Characteristics of Minute Pulmonary Meningothelial-like Nodules. | Lab Invest | 2025 | 40311876 | PubTator, text mining | PubMed |
| Navigating prognostic strategies for GH- and PRL-secreting pituitary neuroendocrine tumors: key insights from a clinicopathological study. | Front Endocrinol (Lausanne) | 2025 | 40276548 | PubTator, text mining | PubMed |
| Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma. | Cell Mol Life Sci | 2025 | 40268793 | PubTator, text mining | PubMed |
| SSTR2 expression in neoplastic and normal anterior pituitary is impacted by age, sex, and hormonal status. | J Neuropathol Exp Neurol | 2025 | 40261909 | PubTator, text mining | PubMed |
| [203/212Pb]Pb-VMT-α-NET as a novel theranostic agent for targeted alpha radiotherapy-first clinical experience. | Eur J Nucl Med Mol Imaging | 2025 | 40202686 | PubTator, text mining | PubMed |
| Somatostatin Receptor 2 Negative Pheochromocytoma Masked by Normal Adrenal Gland on Gallium-68 DOTATATE. | AACE Clin Case Rep | 2025 | 40201467 | PubTator, text mining | PubMed |
| Upregulation of SSTR2 Expression and Radioligand Binding of [18F]SiTATE in Neuroendocrine Tumour Cells with Combined Inhibition of Class I HDACs and LSD1. | Neuroendocrinology | 2025 | 40188826 | PubTator, text mining | PubMed |
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). | BMC Cancer | 2025 | 40186126 | PubTator, text mining | PubMed |
Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study. | Acta Pharm Sin B | 2025 | 40177560 | PubTator, text mining | PubMed |
| Meningioma: Novel Diagnostic and Therapeutic Approaches. | Biomedicines | 2025 | 40149634 | PubTator, text mining | PubMed |
| An SSTR2-somatostatin chemotactic axis drives T cell progenitor homing to the intestines. | Nat Immunol | 2025 | 40140497 | PubTator, text mining | PubMed |
| Successful Conversion Surgery for Locally Advanced Pancreatic Neuroendocrine Carcinoma: A Case Report. | Surg Case Rep | 2025 | 40134936 | PubTator, text mining | PubMed |
| Preoperative PET/MRI and radio-guided surgery using [Cu64]DOTATATE in meningioma: a feasibility study. Illustrative case. | J Neurosurg Case Lessons | 2025 | 40127474 | PubTator, text mining | PubMed |
| Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancer. | Sci Rep | 2025 | 40121305 | PubTator, text mining | PubMed |
| Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients. | Ann Nucl Med | 2025 | 40106206 | PubTator, text mining | PubMed |
| [ 18 F]SiTATE Uptake in a Pancreatic Metastasis From a Renal Cell Carcinoma on a Long Axial Field of View PET/CT. | Clin Nucl Med | 2025 | 40103008 | PubTator, text mining | PubMed |
| [68Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literature. | Oncol Lett | 2025 | 40052066 | PubTator, text mining | PubMed |
| SHP2 inhibition reduces somatotroph tumor growth in a pre-clinical model. | Neuro Oncol | 2025 | 40045561 | PubTator, text mining | PubMed |
| Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. | Br J Clin Pharmacol | 2025 | 40040531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=11